Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other biologically active molecules. Its structure supports the introduction of fluorinated moieties into larger heterocyclic systems, enhancing metabolic stability and binding affinity in drug candidates. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to the electron-withdrawing properties of the difluoro and nitro groups, which influence reactivity and pharmacokinetic profiles. Also utilized in agrochemical research for designing novel active ingredients with improved efficacy and environmental stability.